Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
Clinical trial NCT03018080 · COMPLETED
Trial details
- NCT number
- NCT03018080
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2021-07-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.